United Therapeutics Corporation
UTHR · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $338,700 | $309,500 | $322,200 | $301,300 |
| Dep. & Amort. | $21,900 | $21,100 | $19,800 | $19,700 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $37,800 | $31,800 | $27,000 |
| Change in WC | $162,500 | -$203,000 | $78,000 | -$4,200 |
| Other Non-Cash | $39,000 | $26,300 | $9,400 | -$2,600 |
| Operating Cash Flow | $562,100 | $191,700 | $461,200 | $341,200 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$210,500 | -$62,200 | -$74,900 | -$86,700 |
| Net Acquisitions | $0 | $0 | $0 | -$30,000 |
| Inv. Purchases | -$415,900 | -$1,806,900 | -$692,300 | -$478,500 |
| Inv. Sales/Matur. | $182,500 | $1,569,800 | $611,700 | $478,000 |
| Other Inv. Act. | $584,800 | -$600 | -$9,200 | -$6,000 |
| Investing Cash Flow | $140,900 | -$299,900 | -$164,700 | -$123,200 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | -$211,500 | -$100,000 | -$100,000 |
| Stock Issued | $44,500 | $18,100 | $0 | $0 |
| Stock Repurch. | -$1,000,000 | $0 | $0 | -$300 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$500 | -$5,200 | $6,200 | $25,600 |
| Financing Cash Flow | -$956,000 | -$198,600 | -$93,800 | -$74,700 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$253,000 | -$306,800 | $202,700 | $143,300 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $1,593,100 | $1,899,900 | $1,697,200 | $1,553,900 |
| End Cash | $1,340,100 | $1,593,100 | $1,899,900 | $1,697,200 |
| Free Cash Flow | $351,600 | $129,500 | $386,300 | $254,500 |